Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zuzana Sporikova"'
Autor:
Ondrej Kalita, Lumir Hrabalek, Matej Halaj, Pavel Hok, David Franc, Yvona Klementova, Martin Dolezel, Eva Cechakova, Zuzana Sporikova, Jiri Drabek, Marian Hajduch, Lucie Tuckova
Publikováno v:
Biomedical Papers, Vol 166, Iss 2, Pp 236-241 (2022)
Background. Stroke-like syndrome is defined as a rare, delayed complication of brain oncotherapy. Cases with more favorable brain cancer diagnoses and longer life expectancy have been previously reported, but here we present, for the first time, thre
Externí odkaz:
https://doaj.org/article/d7a52352eed149bba87e1600fc803e11
Autor:
Ondrej Kalita, Zuzana Sporikova, Marian Hajduch, Magdalena Megova Houdova, Rastislav Slavkovsky, Lumir Hrabalek, Matej Halaj, Yvona Klementova, Martin Dolezel, Jiri Drabek, Lucie Tuckova, Jiri Ehrmann, Jana Vrbkova, Radek Trojanec, Miroslav Vaverka
Publikováno v:
Current Oncology, Vol 28, Iss 2, Pp 1280-1293 (2021)
This prospective population-based study on a group of 132 resected IDH-wildtype (IDH-wt) glioblastoma (GBM) patients assesses the prognostic and predictive value of selected genetic biomarkers and clinical factors for GBM as well as the dependence of
Externí odkaz:
https://doaj.org/article/f026a67f57ad4e82bce2e57e883a6eb6
Autor:
Jana Vrbkova, Ondrej Kalita, Marian Hajduch, Zuzana Sporikova, Matej Halaj, Lumir Hrabalek, Martin Dolezel, Jiri Ehrmann, Yvona Klementova, Miroslav Vaverka, Magdalena Megova Houdova, Jiri Drabek, Radek Trojanec, Rastislav Slavkovsky, Lucie Tučková
Publikováno v:
Current Oncology, Vol 28, Iss 122, Pp 1280-1293 (2021)
Current Oncology
Volume 28
Issue 2
Pages 122-1293
Current Oncology
Volume 28
Issue 2
Pages 122-1293
This prospective population-based study on a group of 132 resected IDH-wildtype (IDH-wt) glioblastoma (GBM) patients assesses the prognostic and predictive value of selected genetic biomarkers and clinical factors for GBM as well as the dependence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b1b6d4665905217a7021105ca5715f
https://www.mdpi.com/1718-7729/28/2/122
https://www.mdpi.com/1718-7729/28/2/122
Autor:
Zuzana Sporikova, Rastislav Slavkovsky, Lucie Tuckova, Ondrej Kalita, Magdalena Megova Houdova, Jiri Ehrmann, Marian Hajduch, Lumir Hrabalek, Miroslav Vaverka
Publikováno v:
Applied Immunohistochemistry and Molecular Morphology
Patients below 55 years were genetically studied because the prevalence of isocitrate dehydrogenase 1 (IDH1) decreases in older patients and on grounds of cost-effectiveness, as suggested by the World Health Organization (WHO) in 2016. The aim of our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c609aad2608b28a2f354f392d37718e3
http://publikace.k.utb.cz/handle/10563/1010749
http://publikace.k.utb.cz/handle/10563/1010749
Publikováno v:
Clinical Breast Cancer. 18:e841-e850
Triple-negative breast cancer (TNBC) accounts for 15% to 20% of breast cancer cases and is characterized by the absence of estrogen, progesterone, and human epidermal growth factor 2 receptors. Though TNBC is a highly heterogenic and aggressive disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f30a200140d1e8a1d8ec7781678c61
https://doi.org/10.1016/j.clbc.2018.07.023
https://doi.org/10.1016/j.clbc.2018.07.023
Autor:
Radek Trojanec, M Megova Houdova, Koudeláková, O. Kalita, Jiri Drabek, Jana Vrbkova, Marian Hajduch, Zuzana Sporikova
BACKGROUND: Glioblastoma (GBM) is the most common primary brain tumour in adults with nearly 100% mortality. Despite aggressive therapy, overall survival of GBM patients remains poor due to intrinsic or acquired resistance to maximal treatment modali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3a5acb6279698bd4a6a65c952e392ea
https://europepmc.org/articles/PMC6144043/
https://europepmc.org/articles/PMC6144043/
Autor:
Jana Vrbkova, Jiri Drabek, D Vrana, P Hok, Lucie Tučková, Miroslav Vaverka, Marian Hajduch, Lumir Hrabalek, Zuzana Sporikova, Petr Hluštík, Radek Trojanec, O. Kalita
Publikováno v:
Neuro-Oncology. 20:iii253-iii253
BACKGROUND: Regardless of GBM patient prognosis remains dire, there is a patient group, in which profit from current diagnostic methods and treatment strategies progress has yielded extension of both OS and PFS, that again recall question of recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4491a6a5c8c97eeb2148d48f1aa58ccf
https://doi.org/10.1093/neuonc/noy139.140
https://doi.org/10.1093/neuonc/noy139.140
Autor:
Marian Hajduch, Jiri Drabek, Magdalena Megova, Radek Trojanec, Vladimira Koudelakova, Zuzana Sporikova, Jana Vrbkova, Ondrej Kalita
Publikováno v:
Cancer Research. 78:3695-3695
Background: Glioblastoma (GBM) is the most frequent and the most malignant brain tumor in adults. Despite aggressive therapy, overall survival of GBM patients remains poor due to intrinsic or acquired resistance to combined radiation and chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e9e2fca1d848fff13bfd7054c2f1b4f
https://doi.org/10.1158/1538-7445.am2018-3695
https://doi.org/10.1158/1538-7445.am2018-3695
Autor:
Magdalena Megova, Lumir Hrabalek, Miroslav Vaverka, Jana Vrbkova, Marian Hajduch, Lucie Tučková, Zuzana Sporikova, Radek Trojanec, O. Kalita
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4251be24c85901ebc0c2958be0bbe8
http://europepmc.org/abstract/PMC/PMC5782598
http://europepmc.org/abstract/PMC/PMC5782598